PanTheryx’s Product, DiaResQ®, Selected as a Leading Healthcare Innovation with Great Promise to Transform Global Health

BOULDER, Colorado – (BUSINESS WIRE) – July 16, 2015 – PanTheryx, Inc., a global medical nutrition company based in Boulder, Colorado, announced today its flagship product for pediatric infectious diarrhea, DiaResQ®, has been selected in Reimagining Global Health, the inaugural report of the Innovation Countdown 2030 initiative, as one of the 30 leading healthcare innovations with great promise to transform global health by 2030 and to help accelerate progress toward the new health targets proposed in the United Nations Sustainable Development Goals.

DiaResQ® was one of only 12 innovations recognized in the maternal, newborn and child health categories. Specifically formulated for the dietary needs of children with infectious diarrhea, DiaResQ® is a nutritional intervention that promotes intestinal repair and boosts a child’s natural defenses.

“We are truly honored to have DiaResQ® included in the Innovation Countdown 2030’s Reimagining Global Health report,” said Mark A. Braman, President and CEO of PanTheryx. “This recognition validates what we have always believed – that DiaResQ® is truly a breakthrough nutritional intervention for pediatric diarrhea with the potential to greatly improve the wellbeing and quality of life of millions of children and their families worldwide.”

Infectious diarrhea is a major world health challenge. Globally, approximately 1.7 billion cases occur annually in children under five. Almost 760,000 of these children under five die every year as a result of this condition. Pediatric infectious diarrhea kills nearly as many children as HIV/AIDS, malaria and measles combined.

Led by PATH and supported by the Norwegian Agency for Development Cooperation (Norad), the Bill & Melinda Gates Foundation, and the United States Agency for International Development (USAID), the Innovation Countdown 2030 initiative aims to accelerate high-potential innovations, catalyzing investment and increasing awareness of and support for transformative ideas to improve health and save lives.

The Innovation Countdown initiative asked 5,000 plus experts, innovators and technology developers to identify lifesaving ideas and technologies. Over 500 innovations from more than 50 countries were nominated in eight categories. The nominations were then qualitatively assessed based upon the accessibility and affordability of the innovation, stage of development, expected performance compared to existing solutions, potential impact, and the number of nominations received. Of the 500 nominated innovations, 175 were then submitted to panels of world-renowned health area experts for evaluation and ranking. Of these 175, the top 61 were then submitted to a second independent, interdisciplinary expert panel for final ranking of the top 30 innovations.

A copy of the Reimagining Global Health can be downloaded at: http://ic2030.org/#IC2030

For more information about the Innovation Countdown 2030 initiative, please go to: http://www.path.org/news/press-room/723

 

About PanTheryx:
Founded in 2007, PanTheryx is a global medical nutrition company based in Boulder, Colorado, and is dedicated to improving global health and quality of life through innovative life science. Utilizing its broad-based proprietary technology platform, PanTheryx is focused on the research, development and commercialization of medical nutrition products targeting the gastrointestinal microbiome. The company’s lead product addresses acute infectious diarrhea, a leading cause of death worldwide among children under the age of five. For more information, log on to: www.pantheryx.com and www.diaresq.com.

 

Media Contacts:
Jess Teilborg
JTeilborg@pantheryx.com
(720) 417-7325